304 related articles for article (PubMed ID: 12799424)
21. AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature.
Pettersen HS; Galashevskaya A; Doseth B; Sousa MM; Sarno A; Visnes T; Aas PA; Liabakk NB; Slupphaug G; Sætrom P; Kavli B; Krokan HE
DNA Repair (Amst); 2015 Jan; 25():60-71. PubMed ID: 25486549
[TBL] [Abstract][Full Text] [Related]
22. AID: how does it aid antibody diversity?
Honjo T; Muramatsu M; Fagarasan S
Immunity; 2004 Jun; 20(6):659-68. PubMed ID: 15189732
[TBL] [Abstract][Full Text] [Related]
23. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets.
Chaudhuri J; Khuong C; Alt FW
Nature; 2004 Aug; 430(7003):992-8. PubMed ID: 15273694
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of somatic hypermutation: critical analysis of strand biased mutation signatures at A:T and G:C base pairs.
Steele EJ
Mol Immunol; 2009 Jan; 46(3):305-20. PubMed ID: 19062097
[TBL] [Abstract][Full Text] [Related]
25. Analysis of 6912 unselected somatic hypermutations in human VDJ rearrangements reveals lack of strand specificity and correlation between phase II substitution rates and distance to the nearest 3' activation-induced cytidine deaminase target.
Ohm-Laursen L; Barington T
J Immunol; 2007 Apr; 178(7):4322-34. PubMed ID: 17371989
[TBL] [Abstract][Full Text] [Related]
26. The activation-induced cytidine deaminase (AID) efficiently targets DNA in nucleosomes but only during transcription.
Shen HM; Poirier MG; Allen MJ; North J; Lal R; Widom J; Storb U
J Exp Med; 2009 May; 206(5):1057-71. PubMed ID: 19380635
[TBL] [Abstract][Full Text] [Related]
27. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts.
Yoshikawa K; Okazaki IM; Eto T; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
Science; 2002 Jun; 296(5575):2033-6. PubMed ID: 12065838
[TBL] [Abstract][Full Text] [Related]
28. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification.
Petersen-Mahrt SK; Harris RS; Neuberger MS
Nature; 2002 Jul; 418(6893):99-103. PubMed ID: 12097915
[TBL] [Abstract][Full Text] [Related]
29. Biochemical analysis of hypermutational targeting by wild type and mutant activation-induced cytidine deaminase.
Bransteitter R; Pham P; Calabrese P; Goodman MF
J Biol Chem; 2004 Dec; 279(49):51612-21. PubMed ID: 15371439
[TBL] [Abstract][Full Text] [Related]
30. Somatic hypermutation in immunity and cancer: Critical analysis of strand-biased and codon-context mutation signatures.
Steele EJ
DNA Repair (Amst); 2016 Sep; 45():1-24. PubMed ID: 27449479
[TBL] [Abstract][Full Text] [Related]
31. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.
Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4506-11. PubMed ID: 15767564
[TBL] [Abstract][Full Text] [Related]
32. Analysis of a single-stranded DNA-scanning process in which activation-induced deoxycytidine deaminase (AID) deaminates C to U haphazardly and inefficiently to ensure mutational diversity.
Pham P; Calabrese P; Park SJ; Goodman MF
J Biol Chem; 2011 Jul; 286(28):24931-42. PubMed ID: 21572036
[TBL] [Abstract][Full Text] [Related]
33. Transcription-targeted DNA deamination by the AID antibody diversification enzyme.
Chaudhuri J; Tian M; Khuong C; Chua K; Pinaud E; Alt FW
Nature; 2003 Apr; 422(6933):726-30. PubMed ID: 12692563
[TBL] [Abstract][Full Text] [Related]
34. The mRNA tether model for activation-induced deaminase and its relevance for Ig somatic hypermutation and class switch recombination.
Liu D; Goodman MF; Pham P; Yu K; Hsieh CL; Lieber MR
DNA Repair (Amst); 2022 Feb; 110():103271. PubMed ID: 34990960
[TBL] [Abstract][Full Text] [Related]
35. Reflections on the state of play in somatic hypermutation.
Steele EJ
Mol Immunol; 2008 May; 45(10):2723-6. PubMed ID: 18359085
[TBL] [Abstract][Full Text] [Related]
36. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation.
Durandy A
Eur J Immunol; 2003 Aug; 33(8):2069-73. PubMed ID: 12884279
[TBL] [Abstract][Full Text] [Related]
37. Impact of phosphorylation and phosphorylation-null mutants on the activity and deamination specificity of activation-induced cytidine deaminase.
Pham P; Smolka MB; Calabrese P; Landolph A; Zhang K; Zhou H; Goodman MF
J Biol Chem; 2008 Jun; 283(25):17428-39. PubMed ID: 18417471
[TBL] [Abstract][Full Text] [Related]
38. Strikingly different properties of uracil-DNA glycosylases UNG2 and SMUG1 may explain divergent roles in processing of genomic uracil.
Doseth B; Ekre C; Slupphaug G; Krokan HE; Kavli B
DNA Repair (Amst); 2012 Jun; 11(6):587-93. PubMed ID: 22483865
[TBL] [Abstract][Full Text] [Related]
39. The cell cycle restricts activation-induced cytidine deaminase activity to early G1.
Wang Q; Kieffer-Kwon KR; Oliveira TY; Mayer CT; Yao K; Pai J; Cao Z; Dose M; Casellas R; Jankovic M; Nussenzweig MC; Robbiani DF
J Exp Med; 2017 Jan; 214(1):49-58. PubMed ID: 27998928
[TBL] [Abstract][Full Text] [Related]
40. Activation-induced cytidine deaminase action is strongly stimulated by mutations of the THO complex.
Gómez-González B; Aguilera A
Proc Natl Acad Sci U S A; 2007 May; 104(20):8409-14. PubMed ID: 17488823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
